Muhammad Husnain, MD

Description

I believe in providing compassionate and comprehensive care to my patients. My goal is to provide my patients the guidance and support they need throughout their journey and help them make the right decisions for themselves.

Keywords non germinomatous germ cell tumor, supratentorial primitive neuroectodermal tumor, epithelioid malignant peripheral nerve sheath tumor, teratoma with malignant transformation, immature teratoma, meningothelial meningioma, papillary meningioma, anaplastic meningioma, fibrous meningioma, transitional meningioma, microcystic meningioma, angiomatous meningioma, psammomatous meningioma, secretory meningioma, metaplastic meningioma, chordoid meningioma, clear cell meningioma, lymphomatoid granulomatosis, histiocytic sarcoma, juvenile xanthogranuloma, rosai dorfman disease, meningeal melanomatosis, meningeal melanocytoma, meningeal melanocytosis, meningeal melanoma, plexiform neurofibroma, angioleiomyoma, microsatellite instability, abnormal urine cytology, waldenstrom macroglobulinemia, malignant carcinoid tumor of colon, sweat gland carcinoma, papillary cancer of thyroid, medullary cancer of thyroid, follicular cancer of thyroid, anaplastic cancer of thyroid, tracheal cancer, retroperitoneal mass, non hodgkin lymphoma, myeloproliferative diseases, head and neck tumors, tectal glioma, sacrococcygeal teratoma, pleomorphic xanthoastrocytomas, giant cell tumor of the bone, fibrosarcoma of the head & neck, epithelioid hemangioendothelioma, diffuse intrinsic pontine glioma (dipg), cervical teratoma, bone sarcoma, alveolar soft part sarcoma, adamantinoma, stomach cancer, plasma cell dyscrasia, peutz jeghers syndrome, neuronal glial tumors, musculoskeletal tumor, melanoma of the lip, li fraumeni syndrome, hemolytic uremic syndrome, endometrial cancer, lymphoma, leukemia, hematopoietic stem cell transplant, repeat hematopoietic stem cell transplant, hematopoietic bone marrow transplant, multiple myeloma, bone marrow transplant for multiple myeloma, cancer genomics, targeted molecular therapy, melanotic schwannoma, brain metastases, stomatitis, hemoglobinopathies, thrombocytosis, aplastic anemia, blood disorders, lymphopenia, von willebrand disease, pernicious anemia, hereditary cancer risk, bone marrow disorders, blood cancer, adverse effects to anticoagulants, fanconi anemia, diamond blackfan anemia, thrombophilia, thrombocytopenia, thalassemia, splenomegaly, side effects of cancer treatment, secondary polycythemia, polycythemia, petechiae, pancytopenia, osteosarcoma, neutropenia, myelodysplastic syndrome, lung cancer, leukopenia.